trial

Brain Stimulation and Cognitive Training - Efficacy

NCTId NCT05111548
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Completed
Enrollment 19 (actual)
Sponsored by University of Michigan
Primary completion 2023-04-14
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Completed
Enrollment
19 (actual)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Double
Start
2021-09-08
Primary completion
2023-04-14
Eligibility
ALL · 18 Years · 65 Years

Interventions & indications

Drugs
tDCS (Active)BrainHQtDCS (Inactive)

Sponsors

University of MichiganLead Sponsor

Investigators

1
Cynthia Burton, PhDPrincipal Investigator

Sites

1 total
Ann Arbor, United States

Facts & assertions

4 sourced
Enrollment
19
Phase
NA
Primary Completion Date
2023-04-14
Status
COMPLETED
relationships
The graph out of here
drug
tDCS (Active)
drug
BrainHQ
drug
tDCS (Inactive)
drug
lead_sponsor
University of Michigan
company
indication
Schizo Affective Disorder
indication
Bipolar Disorder
indication
Psychotic Disorders
indication
investigator
Cynthia Burton, PhD
person